Search clinical trials for: EGFR positive NSCLC
Total 15573 results
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruitingNon-small Cell Lung CancerChina
-
Groupe Français de Pneumo-CancérologieRecruitingMechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)Non-small Cell Lung Cancer | EGFR Exon 20 Insertion MutationFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingNSCLC Stage IV | ALK Gene Mutation | ALK Sensitizing MutationItaly
-
Sun Yat-sen UniversityNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Neogene Therapeutics, Inc.RecruitingEndometrial Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Colorectal Carcinoma | Solid Tumor, Adult | KRAS G12DUnited States
-
Jair Bar, M.D., Ph.D.Not yet recruiting
-
Hunan Province Tumor HospitalNot yet recruiting
-
AstraZenecaRecruitingLung CancerSpain, Vietnam, China, India, Taiwan, Thailand, Israel, Turkey, United States, Korea, Republic of
-
Juan LI, MDRecruitingNon Small Cell Lung Cancer | EGFR Exon 20 Insertion MutationChina
-
Hideho Okada, MD, PhDNational Cancer Institute (NCI); California Institute for Regenerative Medicine...RecruitingGlioblastoma | Recurrent Glioblastoma | EGFR Gene Mutation | MGMT-Unmethylated GlioblastomaUnited States
-
Therapex Co., LtdRecruitingCarcinoma, Non-Small-Cell Lung | EGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
National Cancer Center, KoreaRecruitingLazertinibKorea, Republic of
-
Fusion Pharmaceuticals Inc.AstraZenecaRecruitingAdvanced Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Metastatic Colorectal CarcinomaUnited States, Canada
-
Peking Union Medical College HospitalNot yet recruitingNon Small Cell Lung Cancer | Immune Checkpoint Inhibitor | EGFR Exon 21 MutationChina
-
Xueqin YangRecruitingNSCLC | Targeted Therapy | EvaluationChina
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.RecruitingCarcinoma, Non-Small-Cell LungJapan, China, Canada, Spain, Germany, Korea, Republic of, Austria, Brazil, Greece, France, United States, Italy, Argentina, Chile, Hungary, India, Turkey, Romania, Netherlands, Poland, Switzerland
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | Non-small Cell Lung Cancer Stage IV | Non Small Cell Lung Cancer Stage IIIA
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruiting
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | RET Gene Mutation | MET AmplificationChina
-
Samsung Medical CenterNot yet recruitingNon-Small Cell Lung Cancer MetastaticKorea, Republic of
-
Kunming Medical UniversityRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorChina
-
Guangdong Association of Clinical TrialsRecruitingALK Positive Non-small Cell Lung CancerChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNSCLC | EGFR Gene MutationChina
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Taiwan, United States, Australia, Israel, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia, Thailand, Brazil
-
AstraZenecaRecruiting
-
National University Hospital, SingaporeRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | EGFR L858R | EGFR DEL19France
-
Haisco Pharmaceutical Group Co., Ltd.Recruiting
-
Scorpion Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | EGFR/HER2 Exon 20 Insertion MutationUnited States, Taiwan
-
Degan LuWu Jieping Medical FoundationNot yet recruitingLung Cancer | Anlotinib | TKI Resistance | EGFR Sensitive Mutation | Pianzumab
-
Betta Pharmaceuticals Co., Ltd.RecruitingNon-Small Cell Lung Cancer | Adjuvant Therapy | EGFR Sensitive MutationChina
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-Small Cell Lung CancerChina
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation
-
Fudan UniversityRecruitingNon-small Cell Lung Cancer | Brain MetastasesChina
-
Avistone Biotechnology Co., Ltd.Recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingLung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
Teligene USRecruitingNon-small Cell Lung CancerUnited States
-
Sun Yat-sen UniversityRecruitingNon-small Cell Lung CancerChina
-
Jinming YuRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
Shanghai Zhongshan HospitalNingbo No. 1 Hospital; Shanghai Minhang Central Hospital; Xuhui Central Hospital... and other collaboratorsNot yet recruitingNon-Small Cell Lung Cancer
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Not yet recruitingNon-small Cell Lung CancerUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Pancreatic Ductal AdenocarcinomaUnited States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong